Free Trial

NovaBay Pharmaceuticals (NBY) Insider Trading & Ownership

NovaBay Pharmaceuticals logo
$0.60 +0.01 (+2.04%)
As of 04/17/2025 04:00 PM Eastern

NovaBay Pharmaceuticals (NYSE:NBY) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.10%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$188,977.78
Number Of
Insiders Selling
(Last 12 Months)
0
Get NBY Insider Trade Alerts

Want to know when executives and insiders are buying or selling NovaBay Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NBY Insider Buying and Selling by Quarter

NovaBay Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/8/2025Poplar Point Capital PartnersMajor ShareholderBuy300$0.47$141.00  
4/4/2025Poplar Point Capital PartnersMajor ShareholderBuy4,538$0.52$2,359.76  
4/2/2025Poplar Point Capital PartnersMajor ShareholderBuy917$0.58$531.86  
3/31/2025Poplar Point Capital PartnersMajor ShareholderBuy21,654$0.59$12,775.86  
3/28/2025Poplar Point Capital PartnersMajor ShareholderBuy49,400$0.61$30,134.00  
3/26/2025Poplar Point Capital PartnersMajor ShareholderBuy13,292$0.61$8,108.12  
3/24/2025Poplar Point Capital PartnersMajor ShareholderBuy100$0.60$60.00  
3/20/2025Poplar Point Capital PartnersMajor ShareholderBuy5,320$0.61$3,245.20  
3/18/2025Poplar Point Capital PartnersMajor ShareholderBuy14,000$0.63$8,820.00  
3/14/2025Poplar Point Capital PartnersMajor ShareholderBuy25,511$0.63$16,071.93  
3/12/2025Poplar Point Capital PartnersMajor ShareholderBuy11,837$0.62$7,338.94  
3/10/2025Poplar Point Capital PartnersMajor ShareholderBuy14,645$0.58$8,494.10  
3/7/2025Poplar Point Capital PartnersMajor ShareholderBuy102$0.55$56.10  
3/4/2025Poplar Point Capital PartnersMajor ShareholderBuy4,000$0.58$2,320.00  
2/27/2025Poplar Point Capital PartnersMajor ShareholderBuy385$0.61$234.85  
2/25/2025Poplar Point Capital PartnersMajor ShareholderBuy25,033$0.62$15,520.46  
2/20/2025Poplar Point Capital PartnersMajor ShareholderBuy1,836$0.63$1,156.68  
2/18/2025Poplar Point Capital PartnersMajor ShareholderBuy3,222$0.66$2,126.52  
2/3/2025Poplar Point Capital PartnersMajor ShareholderBuy2,597$0.64$1,662.08  
1/31/2025Poplar Point Capital PartnersMajor ShareholderBuy70,685$0.65$45,945.25  
1/27/2025Poplar Point Capital PartnersMajor ShareholderBuy31,703$0.69$21,875.07  
(Data available from 1/1/2013 forward)

NBY Insider Trading Activity - Frequently Asked Questions

The list of insiders at NovaBay Pharmaceuticals includes Poplar Point Capital Partners. Learn more on insiders at NBY.

0.10% of NovaBay Pharmaceuticals stock is owned by insiders. Learn more on NBY's insider holdings.

The following insider purchased NBY shares in the last 24 months: Poplar Point Capital Partners ($188,977.78).

Insiders have purchased a total of 301,077 NBY shares in the last 24 months for a total of $188,977.78 bought.

NovaBay Pharmaceuticals Key Executives

  • Mr. Justin M. Hall Esq. (Age 46)
    President, CEO, General Counsel, Chief Compliance Officer, Corporate Secretary & Director
    Compensation: $364.15k
  • Mr. Tommy Law (Age 39)
    Controller, Interim CFO & Treasurer
    Compensation: $155.48k


This page (NYSE:NBY) was last updated on 4/21/2025 by MarketBeat.com Staff
From Our Partners